专栏名称: 毕凯今选
由毕凯医药为您每周跟踪PUBMED十大瘤种最新前沿进展,编译制作,每日分享推送,希望我们的一点点绵薄之力,能为临床助力,做医生的朋友,做患者的帮助!
今天看啥  ›  专栏  ›  毕凯今选

【其他高分选 062】

毕凯今选  · 公众号  ·  · 2024-09-03 13:50

文章预览

BC PMID: 39189901 IF:12.1 Accuracy of an Artificial Intelligence System for Interval Breast Cancer Detection at Screening Mammography SCI:Radiology PMID:39189475 IF:14.3 mRNA-Lipid Nanoparticle-Mediated Restoration of PTPN14 Exhibits Antitumor Effects by Overcoming Anoikis Resistance in Triple-Negative Breast Cancer SCI:Adv Sci (Weinh) PMID:39187844 IF:10.4 The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models SCI:Genome Med PMID:39187583 IF:38.1 Metal-ion-chelating phenylalanine nanostructures reverse immune dysfunction and sensitize breast tumour to immune checkpoint blockade SCI:Nat Nanotechnol PMID:39193992 IF:29.7 MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer SCI:Cancer Discov PMID:39215346 IF:11.4 USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing Eralpha SCI:J Exp Clin Cancer Res PMID ………………………………

原文地址:访问原文地址
快照地址: 访问文章快照
总结与预览地址:访问总结与预览